Research Progress on Combination of Radiotherapy and Immunotherapy on Advanced Non-small Cell Lung Cancer with Negative Driver Genes
A large proportion of patients with non-small cell lung cancer (NSCLC) are diagnosed with metastatic and incurable advanced lung cancer at the time of discovery, so these patients are given no surgical opportunity and have a low 5-year survival rate. In the era of immunotherapy, many kinds of immune...
Main Authors: | LI Peng, WU Xiaoting, GONG Xiaomei |
---|---|
Format: | Article |
Language: | zho |
Published: |
Magazine House of Cancer Research on Prevention and Treatment
2023-09-01
|
Series: | Zhongliu Fangzhi Yanjiu |
Subjects: | |
Online Access: | http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1533 |
Similar Items
-
A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene‐negative metastatic non‐small cell lung cancer
by: Yanan Wang, et al.
Published: (2024-03-01) -
Advances of Immunotherapy for Non-small Cell Lung Cancer with Driver Gene Mutations
by: SU Chunxia, et al.
Published: (2023-01-01) -
Progress of Research on Radiotherapy Combined with Immunotherapy for Brain Metastases from Non-small Cell Lung Cancer
by: SUN Yichu, et al.
Published: (2023-07-01) -
Progress in radiotherapy for small‐cell lung cancer
by: Fujun Yang, et al.
Published: (2023-09-01) -
Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
by: Huanhuan Li, et al.
Published: (2023-08-01)